|
January 21, 1999 ; American Thoracic Society- Consensus Statement on Dyspnea ... In many cases, the primary problem behind dyspnea involves heart, lung, or neuromuscular abnormalities, which physicians identify by taking a history and doing a physical exam.
|
www.olivija.com/dyspnea/
www.olivija.com/dyspnea/
|
|
|
Dyspnea treatment can be either pharmacologic or non-pharmacological, depending on the dyspnea cause. Both aim to relieve the patient's difficult breathing. ... Overall Dyspnea Treatment and Prognosis...
|
www.lungdiseasefocus.com/articles/emphysema/dyspnea.php
www.lungdiseasefocus.com/articles/emphysema/dyspnea.php
|
|
|
The use of opioids for treatment of dyspnea in patients undergoing palliative care has not been well studied. However, a Cochrane review of the literature found statistically strong evidence that opioids are effective in treating dyspnea in patients with cancer and chronic obstructive pulmonary disease (COPD).
|
www.aafp.org/afp/20030415/tips/14.html
|
|
|
|
The statement points out that the physiologic bases for the treatment of dyspnea lie in the discussion of the mechanisms underlying shortness of breath. The ATS categorizes treatments for dyspnea as related to pathophysiologic mechanisms rather than specific diseases.
|
www.aafp.org/afp/990600ap/special.html
|
|
|
In standard medical therapy treatment for dyspnea is directed toward both alleviating dyspnea and prolonging the patient's life. This is entirely appropriate for many patients. An example would be the administration of ACE (angiotensin converting enzyme) inhibitors for congestive heart failure.
|
www.mywhatever.com/cifwriter/library/70/4942.html
|
|
Treatment of dyspnea is best aimed at the underlying cause. When heart or lung disease can be improved, the sensation of dyspnea is often greatly ameliorated. Severe restrictive lung disease as manifested by pulmonary fibrosis or neuromuscular abnormality poses a particularly difficult problem.
|
www.nlhep.org/books/pul_Pre/dyspnea.html
www.nlhep.org/books/pul_Pre/dyspnea.html
|
|
Controlled trials evaluating inhaled opioids in the treatment of dyspnea in patients with chronic lung diseases have tended to be small and have yielded mixed results. Masood et al.[7] observed that inhaled morphine had no effect on exercise-induced breathlessness in healthy individuals.
|
www.medscape.com/viewarticle/498328
|
|
The other 4 patients had no objective test findings to explain their dyspnea. Five patients had resolution of symptoms when thalidomide was discontinued and, when the drug was resumed at a 50% dose reduction, experienced no further shortness of breath.
|
www.medscape.com/medline/abstract/15811905
|
|
myOptumHealth.com does not provide medical advice, diagnosis or treatment recommendations. It is not a substitute for your doctor or other health care professional's care. The material on this site is for informational purposes only.
|
www.myoptumhealth.com/portal/Health+Hubs/Type2HealthHub...
www.myoptumhealth.com/portal/Health+Hubs/Type2HealthHub/Respiratory/SubTopics/Other+Airway+Diseases
|
|
